Equities
Health CareMedical Equipment and Services
  • Price (EUR)13.90
  • Today's Change0.13 / 0.94%
  • Shares traded58.22k
  • 1 Year change+31.26%
  • Beta1.3128
Data delayed at least 15 minutes, as of Feb 13 2026 16:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

El En SpA is an Italy-based company primarily engaged in the production of laser systems. It controls a group of companies active in the manufacture, research, development, distribution and sale of laser equipment.The Company's range of products includes laser systems for dermatology, surgery, cosmetics, physiotherapy, dentistry and gynaecology, laser systems for cutting, marking and welding of metals, wood, plastic and glass; decoration of leather and fabrics, conservative restoration of works of art. The Company also offers accessories, after-sale services and consulting in the related areas.

  • Revenue in EUR (TTM)--
  • Net income in EUR--
  • Incorporated--
  • Employees1.42k
  • Location
    El En SpAVia Baldanzese, 17CALENZANO 50041ItalyITA
  • Phone+39 558826807
  • Fax+39 558832884
  • Websitehttps://elengroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Synektik SA125.16m22.47m599.52m203.0026.6811.3323.684.7911.099.2061.8026.121.2211.183.60--21.9620.1136.1032.6734.9831.4017.9513.601.4142.090.153--9.1640.2951.5870.0228.82--
Arjo AB (publ)1.04bn31.54m648.00m6.94k22.020.98624.810.62381.231.2340.3927.380.7044.926.221,584,702.002.143.262.914.8042.5943.423.044.780.84944.190.417948.74-2.593.92-32.93-8.68--2.25
Gerresheimer AG2.25bn23.35m687.00m13.54k29.420.49012.460.30530.6760.67665.1540.590.54553.737.85185,328.900.63413.300.87164.6826.8930.041.165.840.52142.080.602241.292.287.90-5.526.3217.58-49.35
Paul Hartmann AG2.43bn81.51m782.36m10.09k9.540.66354.060.322422.9522.95682.93330.051.161.975.54240,745.704.124.215.455.7959.5657.303.563.351.1114.110.246537.952.321.95281.5813.2310.082.71
GVS SpA422.42m22.87m791.71m4.23k31.641.8311.631.870.13230.13232.352.280.4752.027.0199,768.772.576.013.338.5356.1157.985.4111.160.75672.400.4234--0.895913.51144.520.172923.38--
ChemoMetec A/S66.01m23.70m939.77m172.0039.6610.7634.3514.2410.1710.1728.3337.500.65160.66625.542,679,973.0023.3927.4827.9334.0283.8380.5335.9036.413.0695.210.007948.7721.5018.2836.7825.8019.3536.08
Eckert & Ziegler SE304.47m40.62m950.20m1.11k23.144.0416.643.120.64650.63284.853.700.65273.486.10280,619.308.858.6211.0610.4347.2548.5313.5514.182.3768.350.16632.1220.2210.6333.4012.7018.843.30
El En SpA-100.00bn-100.00bn1.12bn1.42k--------------------------7.88--13.94--40.32--8.90------27.62-1.767.1416.0618.96-17.09--
Vitrolife AB324.75m-473.29m1.15bn1.15k--1.54--3.53-37.01-37.0125.3958.290.24073.445.242,987,837.00-35.09-9.46-36.79-9.8658.2457.81-145.74-49.192.7311.330.169---4.6822.53-1,077.00--68.156.58
SKAN Group AG364.55m17.75m1.25bn1.50k70.476.4338.203.430.71950.719514.777.880.90520.70915.33241,201.204.867.699.2816.0374.3872.975.378.890.52416.870.051828.0912.9080.5147.4716.66----
Medartis Holding AG259.41m-534.53k1.31bn1.16k--4.1552.235.04-0.0344-0.034420.2521.030.50820.59865.33249,045.30-0.08280.2609-0.09530.294579.1181.17-0.16290.46953.572.110.32340.006.0511.55469.9510.45-10.60--
Draegerwerk AG & Co KGaA3.42bn120.88m1.49bn16.68k10.850.86895.550.43446.456.45182.3580.561.132.515.01206,009.004.003.725.945.5945.3544.543.533.491.037.960.163716.12-0.07783.9212.6537.910.468359.64
Oxford Nanopore Technologies PLC235.43m-164.85m1.51bn1.33k--2.50--6.42-0.1515-0.15150.21640.54460.29360.86083.25155,672.30-20.56-19.53-24.11-22.7057.3255.04-70.02-77.673.89--0.0777--7.9728.615.38--9.93--
AddLife AB986.05m52.88m1.54bn2.30k30.053.0911.871.564.604.6085.6944.660.81053.835.874,549,891.004.363.826.055.8038.0937.805.384.660.62573.680.467131.711.5214.64122.221.5822.470.00
Data as of Feb 13 2026. Currency figures normalised to El En SpA's reporting currency: Euro EUR

Institutional shareholders

24.77%Per cent of shares held by top holders
HolderShares% Held
Van Lanschot Kempen Investment Management NVas of 29 Apr 20255.24m6.51%
Alantra EQMC Asset Management SGIIC SAas of 22 Oct 20254.79m5.96%
The Vanguard Group, Inc.as of 04 Feb 20261.73m2.16%
Arca Fondi SGR SpAas of 30 Dec 20251.53m1.90%
Norges Bank Investment Managementas of 30 Jun 20251.36m1.70%
Fideuram Asset Management SGR SpAas of 31 Dec 20251.34m1.67%
Praude Asset Management Ltd.as of 31 Aug 20251.27m1.57%
Goldman Sachs Asset Management BVas of 31 Oct 2025988.86k1.23%
ANIMA Sgr SpAas of 30 Jun 2025873.95k1.09%
Mediolanum Gestione Fondi SGRpAas of 30 Sep 2025792.29k0.99%
More ▼
Data from 31 Aug 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.